Kids First Research Act of 2013
A BILL
To eliminate taxpayer financing of presidential campaigns and party conventions and reprogram savings to provide for a 10-year pediatric research initiative through the Common Fund administered by the National Institutes of Health, and for other purposes.
Sec. 2 Termination of taxpayer financing of presidential election campaigns
“(d) Termination—This section shall not apply to taxable years ending on or after the date of the enactment of this subsection.”
“9014. Termination
“The provisions of this chapter shall not apply with respect to any presidential election (or any presidential nominating convention) after the date of the enactment of this section, or to any candidate in such an election.”
“(d) Conversion to 10-Year pediatric research initiative fund
“(1) Conversion—Effective on the date of the enactment of the Kids First Research Act of 2013—
“(A) the special fund established under this section shall be known and designated as the “10-Year Pediatric Research Initiative Fund”; and
“(B) all amounts in the fund as of such date shall be available only for the purpose provided in section 402A(a)(2) of the Public Health Service Act, and only to the extent and in such amounts as are provided in advance in appropriation Acts.
“(2) Termination—Any amounts in the fund that remain unobligated on October 1, 2024, shall be deposited into the general fund of the Treasury.”
“9043. Termination
“The provisions of this chapter shall not apply to any candidate with respect to any presidential election after the date of the enactment of this section.”
Sec. 3 10–Year Pediatric Research Initiative
“(7)
“(A) shall, through the Division of Program Coordination, Planning, and Strategic Initiatives—
“(i) identify research that represents important areas of emerging scientific opportunities, rising public health challenges, or knowledge gaps that deserve special emphasis and would benefit from conducting or supporting additional research that involves collaboration between 2 or more national research institutes or national centers, or would otherwise benefit from strategic coordination and planning;
“(ii) include information on such research in reports under section 403; and
“(iii) in the case of such research supported with funds referred to in subparagraph (B)—
“(I) require as appropriate that proposals include milestones and goals for the research;
“(II) require that the proposals include timeframes for funding of the research; and
“(III) ensure appropriate consideration of proposals for which the principal investigator is an individual who has not previously served as the principal investigator of research conducted or supported by the National Institutes of Health;
“(B)
“(i) may, with respect to funds reserved under section 402A(c)(1) for the Common Fund, allocate such funds to the national research institutes and national centers for conducting and supporting research that is identified under subparagraph (A); and
“(ii) shall, with respect to funds appropriated to the Common Fund under section 402A(a)(2), allocate such funds to the national research institutes and national centers for making grants for pediatric research that is identified under subparagraph (A); and
“(C) may assign additional functions to the Division in support of responsibilities identified in subparagraph (A), as determined appropriate by the Director;”
“(1) This title—For purposes of carrying out this title”
“(2) Funding for 10-year pediatric research initiative through common fund—For carrying out section 402(b)(7)(B)(ii), there is authorized to be appropriated, out of funds in the 10–Year Pediatric Research Initiative Fund established by section 9006 of the Internal Revenue Code of 1986, and in addition to amounts otherwise made available under paragraph (1) of this subsection and reserved under subsection (c)(1)(B)(i) of this section, $13,000,000 for each of fiscal years 2014 through 2023.”
Sec. 4 Prohibition against NIH research on health economics
“(f) Health economics research
“(1) Ongoing research—Before continuing any health economics research grant, project, or activity that is ongoing as of the date of the enactment of this subsection, the Director of NIH shall submit to the Congress a report that outlines the justification for such ongoing grant, project, or activity, including the reason for giving priority to such ongoing grant, project, or activity over research on pediatric diseases and disorders, such as autism, cancer, and other pediatric genetic disorders without cures.
“(2) New research—The Director of NIH may not initiate any health economics research grant, project, or activity until—
“(A) the Director has submitted the report described in paragraph (1); and
“(B) a Federal law has been enacted authorizing the National Institutes of Health to use funding specifically for health economics research.”